The Surge In Diabetes Propels Point-Of-Care Glucose Testing Market Growth Driver: Leading Transformation in the Point-of-Care Glucose Testing Market in 2025

What industry-specific factors are fueling the growth of the point-of-care glucose testing market?
The rising occurrence of diabetes is anticipated to stimulate the expansion of the point-of-care glucose testing market in the future. Diabetes, a persistent metabolic illness, heightens blood sugar levels, ultimately causing significant harm to the heart, blood vessels, eyes, kidneys, and nervous system. Point-of-care glucose testing, which is commonly employed to gauge glucose levels in hospitalised patients, aids in making immediate treatment decisions following shifts in glycemia, improving therapeutic effects and diabetes management. For example, in June 2024, The National Health Service (NHS England), a UK-based publicly funded healthcare system, reported that the number of people identified as pre-diabetic by the NHS in England in 2023 was 3,615,330, reflecting an 18% rise from 3,065,825 in 2022. Furthermore, there was almost a 25% spike in cases amongst those under 40, increasing from 173,166 in 2022 to 216,440 in 2023. Consequently, the escalating incidence of diabetes is fuelling the growth of the point-of-care glucose testing market.

Get Your Point-of-Care Glucose Testing Market Report Here:
https://www.thebusinessresearchcompany.com/report/point-of-care-glucose-testing-global-market-report

What Is the projected market size and growth rate for the point-of-care glucose testing market?
The market size for point-of-care glucose testing has followed a constant expansion trajectory in the past few years. It's anticipated to rise from $4.91 billion in 2024 to $5.15 billion in 2025, charting a compound annual growth rate (CAGR) of 4.9%. The prior growth period's expansion is attributed to factors such as an increase in diabetes occurrence, heightened sensibilities towards diabetes management, an expanding elderly population, enhanced healthcare infrastructure, and the uptake of point-of-care testing.

The market size for point-of-care glucose testing is projected to witness a major surge in the coming years. The growth is expected to reach $6.51 billion by 2029, with a compound annual growth rate (CAGR) of 6.0%. This estimated growth during the forecast period is attributed to the increasing expansion of telemedicine services, a growing focus on personalized medicine for diabetes care, an upsurge in diabetes management programs, enhanced investment in glucose testing research and development, and the adoption of continuous glucose monitoring. The forecast period is also expected to see major trends including the creation of wearable glucose monitoring devices, the incorporation of smartphone connectivity for glucose testing, a rise in point-of-care testing in home healthcare scenarios, the implementation of artificial intelligence in glucose data scrutiny, and the broadening of remote patient supervision for diabetes.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12207&type=smp

What are the emerging trends shaping the future of the point-of-care glucose testing market?
The principal trend sweeping through the point-of-care glucose testing market is product innovation. This is largely being driven by leading companies in the market which are keen on creating novel products to reinforce their market dominance. For example, in January 2022, F. Hoffmann-La Roche AG, a healthcare corporation based in Switzerland, rolled out the Cobas Pulse. This new point-of-care blood glucose monitor designed for healthcare personnel is equipped with a gadget that resembles a touchscreen smartphone and runs specific apps. The hand-held Cobas Pulse features a mechanized glucose test strip reader, camera, and touchscreen for recording diagnostic information. In a robust, disinfectable casing, this device can be safely utilized in patients across all age groups, including infants and those in intensive care. Its operation even extends to improve physicians' work process by integrating Glucommander dosage software into the blood glucose reader and providing access to decision-support applications developed by firms such as Smart4Diagnostics, CardioSignal, and SteadySense.

What major market segments define the scope and growth of the point-of-care glucose testing market?
The point-of-care glucose testing market covered in this report is segmented -

1) By Product: Lancet And Lancing Devices, Strips, Meters
2) By Testing Site: Fingertips, Alternate Site Testing
3) By Applications: Type-1 Diabetes, Type-2 Diabetes
4) By End-User: Professional Diagnostic Centers, Hospitals And Clinics, Home Care Settings, Other End Users

Subsegments:
1) By Lancet And Lancing Devices: Single-Use Lancets, Multi-Use Lancets, Adjustable Lancing Devices
2) By Strips: Glucose Test Strips, ket*one Test Strips, Combo Strips (Glucose And ket*one)
3) By Meters: Blood Glucose Meters, Continuous Glucose Monitoring (CGM) Meters, Bluetooth-Enabled Meters

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12207

Which region dominates the point-of-care glucose testing market?
North America was the largest region in the point-of-care glucose testing market in 2024. The regions covered in the point-of-care glucose testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the point-of-care glucose testing industry growth?
Major companies operating in the point-of-care glucose testing market include F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Danaher Corporation, Siemens Healthineers, Becton, Dickinson and Company, TaiDoc Technology Corporation, B. Braun Melsungen AG, Beckman Coulter Inc., Nipro Corporation, Dexcom Inc., Bio-Rad Laboratories Inc., LifeScan Inc., Nova Biomedical Corporation, Ypsomed AG, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Radiometer Medical ApS, HemoCue AB, EKF Diagnostics Holdings plc, Trinity Biotech plc, Bionime Corporation, PTS Diagnostics, ForaCare Inc., Menarini Diagnostics, ACON Laboratories Inc., Senseonics Holdings Inc., Prodigy Diabetes Care LLC, Nemaura Medical Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12207&type=smp

What Is Covered In The Point-of-Care Glucose Testing Global Market Report?

• Market Size Forecast: Examine the point-of-care glucose testing market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the point-of-care glucose testing market for a structured understanding.
• Key Players Overview: Analyze major players in the point-of-care glucose testing market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the point-of-care glucose testing market.
• Segment Contributions: Evaluate how different segments drive overall growth in the point-of-care glucose testing market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the point-of-care glucose testing market.
• Industry Challenges: Identify potential risks and obstacles affecting the point-of-care glucose testing market.
• Competitive Landscape: Review strategic developments in the point-of-care glucose testing market, including expansions, agreements, and new product launches.

Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.

Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.